
IndraLab
Statements
Atorvastatin inhibits NLRP3. 14 / 14
|
14
reach
"Later, this group found that NEXN-AS1 and NEXN can be significantly induced by the cholesterol-lowering agent atorvastatin, which decreased expression of pyroptosis-related proteins, including NLRP3, caspase-1, GSDMD, IL-1β, and IL-18, in human vascular ECs (HVECs).83 Knockdown of NEXN-AS1 or RNA interference of NEXN abrogates the inhibitory effect of atorvastatin on pyroptosis, indicating the critical regulatory role of NEXN-AS1/NEXN in transferring the anti-pyroptotic signal from atorvastatin to the NLRP3 inflammasome.83
Myocardial I/R injury and myocardial infarction."